HIMX
Himax Technologies, Inc.
HIMX's outlook is improving despite an expensive valuation.
NVDA
NVIDIA Corporation
NVDA has the edge over HIMX overall, supported by stronger valuation and stronger fundamentals.
HIMX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Strong |
HIMX's balance sheet is currently strong, and its revenue and profitability are stable, but its cash flow is under pressure.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
HIMX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.5x | $0.89 | -90% |
| Fair | 16x | $3.12 | -65% |
| Expensive | 44x | $8.79 | -1.8% |
| Current | 45x | $8.96 | — |
Historical ranges are pointers, not guarantees.
HIMX's PE is in its expensive range at 45x.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over HIMX in the historical PE scenario, which offers more potential upside but is not a forecast.
HIMX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect HIMX's earnings to grow and its profitability to improve, with its revenue holding steady.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
HIMX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.20 | -52% |
| Q1 2026 | $0.18 | -63% |
| Q4 2025 | $0.25 | -46% |
| Q3 2025 | $0.35 | -22% |
| Q2 2025 | $0.42 | -4.5% |
| Q1 2025 | $0.49 | +81% |
| Q4 2024 | $0.46 | +64% |
| Q3 2024 | $0.45 | +15% |
HIMX's earnings per share have fallen from their peak: $0.20 over the past year, against $2.78 in early 2022.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over HIMX on earnings, with more consistent year-over-year improvement.
HIMX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $227.4M | +5.9% |
| Q1 2026 | $199M | -7.5% |
| Q4 2025 | $203.1M | -14% |
| Q3 2025 | $196.7M | -12% |
| Q2 2025 | $214.8M | -10% |
| Q1 2025 | $215.1M | +3.7% |
| Q4 2024 | $237.2M | +4.2% |
| Q3 2024 | $222.4M | -6.8% |
HIMX's revenue is recovering but still below its 2021 peak: $227M last quarter, up 5.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 11% | +2.4 points |
| Q1 2026 | 5.1% | -4.1 points |
| Q4 2025 | 3.4% | -6.4 points |
| Q3 2025 | -0.3% | -2.9 points |
| Q2 2025 | 8.4% | -3.8 points |
| Q1 2025 | 9.2% | +4.4 points |
| Q4 2024 | 9.7% | +2.4 points |
| Q3 2024 | 2.6% | -2 points |
HIMX's operating margin was 11% last quarter, up 2.4 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over HIMX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over HIMX on profitability, with a higher operating margin.
HIMX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $13.2M | -76% |
| Q1 2026 | $1.2M | -98% |
| Q4 2025 | $12.7M | -61% |
| Q3 2025 | $55K | +$5.8M |
| Q2 2025 | $55.9M | +150% |
| Q1 2025 | $50.8M | -5.8% |
| Q4 2024 | $32.2M | -41% |
| Q3 2024 | -$5.7M | -143% |
HIMX still generates free cash flow, though less than at its 2021 peak: $27M over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over HIMX on cash flow, with more consistent year-over-year improvement.
HIMX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -0.1% | -118K shares |
| 3 years | -0.1% | -246K shares |
| 5 years | -0.2% | -303K shares |
| Available history | +1.1% | +1.9M shares |
HIMX has 174M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $3.9M |
| Q1 2025 | — |
| Q4 2024 | $3M |
| Q3 2024 | — |
HIMX hasn't bought back shares in the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over HIMX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
HIMX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -3.4x | Net Cash |
| Q1 2026 | -3.4x | Net Cash |
| Q4 2025 | -2.8x | Net Cash |
| Q3 2025 | -2.3x | Net Cash |
| Q2 2025 | 2.2x | Moderate |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 3.1x | Elevated |
| Q3 2024 | 3.7x | Elevated |
HIMX has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
HIMX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.7 | Neutral |
| Stochastic | 12.8 | Oversold |
HIMX's weekly RSI is 37 (neutral) and its Stochastic is 13 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
HIMX PE vs Technology Sector
| Metric | HIMX | Sector median | Relative |
|---|---|---|---|
| PE | 45x | 28x | 62% above |
| PE % | 83 | 35 | 48 pts above |
HIMX is trading at 45x earnings, a 62% premium to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over HIMX on valuation relative to its sector.
HIMX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.8 | 24% below |
| 20 week MA | $13.0 | 31% below |
| 50 week MA | $12.0 | 26% below |
| 100 week MA | $10.3 | 13% below |
| 200 week MA | $8.34 | 7.4% above |
HIMX has fallen below most of its moving averages, though it's still 7.4% above its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
HIMX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.50 | $6.76 | +170% |
| 2021 | $6.76 | $12.5 | +84% |
| 2022 | $12.5 | $6.72 | -46% |
| 2023 | $6.72 | $6.07 | -9.7% |
| 2024 | $6.07 | $7.96 | +31% |
| 2025 | $7.96 | $8.35 | +4.9% |
| 2026 YTD | $8.35 | $8.96 | +7.3% |
HIMX has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.